Shannon Delaney1, Brian Fallon2, Armin Alaedini3, Robert Yolken4, Alyssa Indart3, Tianshu Feng5, Yuanjia Wang5, Daniel Javitt2. 1. Department of Psychiatry, Columbia University Medical Center, New York, NY 10032, United States of America. Electronic address: sld2158@cumc.columbia.edu. 2. Department of Psychiatry, Columbia University Medical Center, New York, NY 10032, United States of America. 3. Department of Medicine, Columbia University Medical Center, New York, NY 10032, United States of America. 4. Johns Hopkins School of Medicine, Baltimore, MD 21218, United States of America. 5. Mailman School of Public Health, Columbia University New York, NY 10032, United States of America.
Abstract
BACKGROUND: Immunological, nutritional, and microbial factors have been implicated in the pathophysiology of schizophrenia, but the interrelationship among measures is understudied. In particular, an increase in the levels of the pro-inflammatory cytokine interleukin-6 (IL-6) is associated with all phases of the illness, and may be associated with other inflammatory markers. Vitamin D is a modulator of the immune system, and LPS antibodies are an indirect measure of gut barrier function. In this study we investigated potential contributing inflammatory mechanisms for IL-6 elevation. METHODS: We compared the levels of vitamin D, C-reactive protein (CRP), antibodies to lipopolysaccharide (LPS), and IL-6 in children, adolescents and young adults with psychosis (n = 47), individuals at clinical high risk for psychosis (n = 17) and unaffected comparison controls (n = 33). Participants were diagnosed by a psychiatrist, using a structured interview, the MINI-Neuropsychiatric Interview. 25(OH)D was measured in serum using chemiluminescent micro particle immunoassay, and anti-LPS antibodies, CRP and IL-6 levels were measured by ELISA. RESULTS: IL-6 and C-reactive protein levels were significantly elevated in the psychosis group relative to the unaffected control subjects. In the psychosis group, levels of IL-6 correlated positively with IgA anti-LPS antibodies and negatively correlated with vitamin D. CONCLUSIONS: Our findings show a significant correlation between IL-6, anti-LPS antibodies and vitamin D deficiency in psychosis, suggesting the existence of multiple potential pathways related to IL-6 elevation in psychosis, and therefore multiple potential strategies for risk mitigation. Collectively these findings support hypotheses regarding interrelated inflammatory contributions to the pathophysiology of psychosis.
BACKGROUND: Immunological, nutritional, and microbial factors have been implicated in the pathophysiology of schizophrenia, but the interrelationship among measures is understudied. In particular, an increase in the levels of the pro-inflammatory cytokine interleukin-6 (IL-6) is associated with all phases of the illness, and may be associated with other inflammatory markers. Vitamin D is a modulator of the immune system, and LPS antibodies are an indirect measure of gut barrier function. In this study we investigated potential contributing inflammatory mechanisms for IL-6 elevation. METHODS: We compared the levels of vitamin D, C-reactive protein (CRP), antibodies to lipopolysaccharide (LPS), and IL-6 in children, adolescents and young adults with psychosis (n = 47), individuals at clinical high risk for psychosis (n = 17) and unaffected comparison controls (n = 33). Participants were diagnosed by a psychiatrist, using a structured interview, the MINI-Neuropsychiatric Interview. 25(OH)D was measured in serum using chemiluminescent micro particle immunoassay, and anti-LPS antibodies, CRP and IL-6 levels were measured by ELISA. RESULTS:IL-6 and C-reactive protein levels were significantly elevated in the psychosis group relative to the unaffected control subjects. In the psychosis group, levels of IL-6 correlated positively with IgA anti-LPS antibodies and negatively correlated with vitamin D. CONCLUSIONS: Our findings show a significant correlation between IL-6, anti-LPS antibodies and vitamin Ddeficiency in psychosis, suggesting the existence of multiple potential pathways related to IL-6 elevation in psychosis, and therefore multiple potential strategies for risk mitigation. Collectively these findings support hypotheses regarding interrelated inflammatory contributions to the pathophysiology of psychosis.
Authors: Gregory P Strauss; Kelsey I Macdonald; Ivan Ruiz; Ian M Raugh; Lisa A Bartolomeo; Sydney H James Journal: Eur Arch Psychiatry Clin Neurosci Date: 2021-04-21 Impact factor: 5.270
Authors: Esmé Jansen van Vuren; Stephan F Steyn; Christiaan B Brink; Marisa Möller; Francois P Viljoen; Brian H Harvey Journal: Biomed Pharmacother Date: 2021-01-01 Impact factor: 6.529
Authors: Alejandra Vargas-Caraveo; Aline Sayd; Javier Robledo-Montaña; Javier R Caso; José L M Madrigal; Borja García-Bueno; Juan C Leza Journal: J Neuroinflammation Date: 2020-01-06 Impact factor: 8.322
Authors: Jenelle Marcelle Safadi; Alice M G Quinton; Belinda R Lennox; Philip W J Burnet; Amedeo Minichino Journal: Mol Psychiatry Date: 2021-02-08 Impact factor: 15.992